Short answer
Neuronetics, Inc. (STIM) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). $30.0M gross equity offering: 18.75M shares at $1.60 each, creating substantial dilution risk.
Neuronetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $30.0M gross equity offering: 18.75M shares at $1.60 each, creating substantial dilution risk
- Underwriters hold a 30-day option for 2.8125M additional shares, potentially increasing proceeds and dilution
- Expected net proceeds $27.7M, rising to $31.9M if the option is fully exercised
- Proceeds partly earmarked for repaying high-cost Perceptive debt: $65M outstanding at 11.5% interest as of September 30, 2026
- Remaining funds support sales, R&D, acquisitions, inventory, working capital and capital expenditures; closing expected November 12, 2026
Item 8.01 · Other Events
- Neuronetics launched an offering on November 10, 2026, signaling planned external financing
- Offering pricing announced the same day, with terms and proceeds detailed in Exhibit 99.2
- Financing appears tied to liquidity needs, including conditions under Amendment No. 6 to the Perceptive Facility
- Amendment No. 6 must satisfy conditions by November 30, 2026, creating near-term execution risk
- Investor focus: offering dilution, proceeds, and impact on cash runway and going-concern risk
Item EX-99.1 · Exhibit EX-99.1
- Proposed underwritten common-stock offering, with Neuronetics selling all shares and underwriters holding a 15% overallotment option
- Offering size, price and timing remain undetermined, creating potential shareholder dilution once finalized
- Proceeds intended partly for at least $15 million prepayment on Perceptive term loans
- Perceptive amendment would reduce revenue covenants, potentially resolving the going-concern risk cited in recent 10-Q filings
- Amendment terminates automatically if conditions, including prepayment, are unmet by November 30, 2026
Item EX-99.2 · Exhibit EX-99.2
- $30 million equity offering priced at $1.60 per share, creating substantial dilution for existing shareholders
- 18,750,000 shares offered, with underwriters’ 30-day option for 2,812,500 additional shares
- Proceeds earmarked partly for term-loan repayment, including at least $15 million required under the Perceptive Sixth Amendment
- Covenant relief could resolve the going-concern risk, but depends on closing and satisfying conditions by November 30, 2026
- Remaining proceeds support sales, R&D, acquisitions, inventory, working capital and capital expenditures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Neuronetics, Inc. 8-K filings
Get the next STIM 8-K as it lands
Follow STIM for push alerts, or ask the research agent what this filing means.